Symbols / ZVSA $0.18 -9.90% ZyVersa Therapeutics, Inc.

Healthcare • Biotechnology • United States • OQB
ZVSA Chart
About

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.46M
Enterprise Value 1.52M Income -24.95M Sales —
Book/sh -1.45 Cash/sh 0.01 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -0.04 PEG —
P/S — P/B -0.12 P/C —
EV/EBITDA -0.22 EV/Sales — Quick Ratio 0.01
Current Ratio 0.03 Debt/Eq — LT Debt/Eq —
EPS (ttm) -4.18 EPS next Y -4.80 EPS Growth —
Revenue Growth — Earnings 2026-05-12 ROA -40.84%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 8.10M
Shs Float 7.68M Short Float 7.38% Short Ratio 0.25
Short Interest — 52W High 1.94 52W Low 0.11
Beta — Avg Volume 71.80K Volume 9.57K
Target Price — Recom None Prev Close $0.20
Price $0.18 Change -9.90%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.18
Latest analyst target
3. DCF / Fair value
$-7.02
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.18
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-03-26 reit HC Wainwright & Co. Buy → Buy $12
2024-03-12 main HC Wainwright & Co. Buy → Buy $12
2024-02-29 reit HC Wainwright & Co. Buy → Buy $24
News
RSS: Latest ZVSA news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
6.84
-25.09%
9.14
-36.64%
14.42
+10.82%
13.01
Research And Development
1.11
-37.44%
1.78
-44.53%
3.21
-40.69%
5.41
Selling General And Administration
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
General And Administrative Expense
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
Other Gand A
5.73
-22.10%
7.36
-34.38%
11.21
+47.44%
7.61
Total Expenses
6.84
-25.09%
9.14
-36.64%
14.42
+10.82%
13.01
Operating Income
-6.84
+25.09%
-9.14
+36.64%
-14.42
-10.82%
-13.01
Total Operating Income As Reported
-25.49
-179.01%
-9.14
+91.52%
-107.75
-728.05%
-13.01
EBITDA
-25.29
-177.01%
-9.13
+36.64%
-14.41
-5.88%
-13.61
Normalized EBITDA
-6.64
+27.24%
-9.13
-111.57%
78.92
+706.95%
-13.00
Reconciled Depreciation
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
EBIT
-25.29
-176.80%
-9.14
+36.64%
-14.42
-5.88%
-13.62
Total Unusual Items
-18.65
0.00
+100.00%
-93.33
-15276.16%
-0.61
Total Unusual Items Excluding Goodwill
-18.65
0.00
+100.00%
-93.33
-15276.16%
-0.61
Special Income Charges
-18.65
0.00
+100.00%
-93.33
0.00
Other Special Charges
—
—
—
—
Impairment Of Capital Assets
—
0.00
-100.00%
11.90
0.00
Write Off
18.65
0.00
-100.00%
81.44
0.00
Net Income
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Pretax Income
-25.80
-174.32%
-9.41
+91.27%
-107.75
-667.06%
-14.05
Net Non Operating Interest Income Expense
-0.51
-90.18%
-0.27
-59149.45%
0.00
+100.11%
-0.43
Interest Expense Non Operating
0.51
+90.18%
0.27
—
0.43
Net Interest Income
-0.51
-90.18%
-0.27
-59149.45%
0.00
+100.11%
-0.43
Interest Expense
0.51
+90.18%
0.27
—
0.43
Interest Income Non Operating
—
—
0.00
—
Interest Income
—
—
0.00
—
Other Income Expense
-18.45
—
-93.33
-15276.16%
-0.61
Other Non Operating Income Expenses
0.20
—
—
—
Gain On Sale Of Security
—
—
—
-0.61
Tax Provision
-0.85
-12726.52%
0.01
+100.07%
-9.46
0.00
Tax Rate For Calcs
0.00
-84.28%
0.00
+139.31%
0.00
0.00
Tax Effect Of Unusual Items
-0.62
0.00
+100.00%
-8.19
0.00
Net Income Including Noncontrolling Interests
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income From Continuing Operation Net Minority Interest
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income From Continuing And Discontinued Operation
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Net Income Continuous Operations
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Normalized Income
-6.92
+26.49%
-9.41
+28.44%
-13.15
+2.13%
-13.44
Net Income Common Stockholders
-24.95
-165.07%
-9.41
+91.14%
-106.25
-341.53%
-24.06
Diluted EPS
—
-8.48
+99.22%
-1,089.70
-214.49%
-346.50
Basic EPS
—
-8.48
+99.22%
-1,089.70
-214.49%
-346.50
Basic Average Shares
—
1.11
+1038.50%
0.10
+41.05%
0.07
Diluted Average Shares
—
1.11
+1038.50%
0.10
+41.05%
0.07
Diluted NI Availto Com Stockholders
-24.95
-165.07%
-9.41
+91.14%
-106.25
-341.53%
-24.06
Preferred Stock Dividends
—
—
7.95
-20.64%
10.02
Total Other Finance Cost
—
0.27
+59149.45%
-0.00
—
Line Item Trend 2024-12-31 2023-12-31
Total Assets
20.60
-6.85%
22.11
Current Assets
1.72
-48.83%
3.35
Cash Cash Equivalents And Short Term Investments
1.53
-51.21%
3.14
Cash And Cash Equivalents
1.53
-51.21%
3.14
Cash Financial
1.53
-51.21%
3.14
Prepaid Assets
0.00
0.00
Other Current Assets
0.18
-14.20%
0.22
Total Non Current Assets
18.88
+0.65%
18.76
Net PPE
0.00
-100.00%
0.01
Gross PPE
0.05
-13.10%
0.06
Accumulated Depreciation
-0.05
-15.38%
-0.05
Other Properties
0.05
-13.10%
0.06
Goodwill And Other Intangible Assets
18.65
+0.00%
18.65
Goodwill
—
0.00
Other Intangible Assets
18.65
+0.00%
18.65
Non Current Deferred Assets
0.06
0.00
Non Current Prepaid Assets
0.18
+81.24%
0.10
Total Liabilities Net Minority Interest
12.08
+9.45%
11.04
Current Liabilities
11.23
+10.17%
10.19
Payables And Accrued Expenses
11.22
+15.96%
9.68
Payables
9.34
+10.74%
8.43
Accounts Payable
9.34
+10.74%
8.43
Current Accrued Expenses
1.89
+51.27%
1.25
Total Tax Payable
—
0.00
Income Tax Payable
—
0.00
Current Debt And Capital Lease Obligation
—
0.01
Current Debt
—
—
Other Current Borrowings
—
—
Current Capital Lease Obligation
0.00
-100.00%
0.01
Current Deferred Liabilities
—
—
Other Current Liabilities
0.01
-98.57%
0.51
Total Non Current Liabilities Net Minority Interest
0.85
+0.80%
0.84
Non Current Deferred Liabilities
0.85
+0.80%
0.84
Non Current Deferred Taxes Liabilities
0.85
+0.80%
0.84
Stockholders Equity
8.52
-23.10%
11.07
Common Stock Equity
8.52
-23.10%
11.07
Capital Stock
0.00
+514.63%
0.00
Common Stock
0.00
+527.50%
0.00
Preferred Stock
0.00
+0.00%
0.00
Share Issued
2.51
+518.99%
0.41
Ordinary Shares Number
2.51
+518.99%
0.41
Treasury Shares Number
0.00
+16.67%
0.00
Additional Paid In Capital
121.16
+6.00%
114.30
Retained Earnings
-112.63
-9.12%
-103.22
Treasury Stock
0.01
+0.00%
0.01
Total Equity Gross Minority Interest
8.52
-23.10%
11.07
Total Capitalization
8.52
-23.10%
11.07
Working Capital
-9.52
-39.08%
-6.84
Invested Capital
8.52
-23.10%
11.07
Total Debt
0.00
-100.00%
0.01
Net Debt
—
—
Capital Lease Obligations
0.00
-100.00%
0.01
Net Tangible Assets
-10.13
-33.78%
-7.57
Tangible Book Value
-10.13
-33.78%
-7.57
Interest Payable
0.27
—
Other Equity Interest
—
—
Preferred Stock Equity
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Cash Flow From Continuing Operating Activities
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Net Income From Continuing Operations
-24.95
-165.07%
-9.41
+90.42%
-98.30
-599.75%
-14.05
Depreciation Amortization Depletion
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Depreciation
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Depreciation And Amortization
0.00
-100.00%
0.01
-33.34%
0.01
+5.39%
0.01
Other Non Cash Items
0.24
+17.30%
0.20
-89.34%
1.92
+1507.01%
0.12
Stock Based Compensation
0.22
-68.42%
0.71
-40.86%
1.19
-66.16%
3.52
Asset Impairment Charge
18.71
0.00
-100.00%
93.33
0.00
Deferred Tax
-0.85
-12726.52%
0.01
+100.07%
-9.48
0.00
Deferred Income Tax
-0.85
-12726.52%
0.01
+100.07%
-9.48
0.00
Operating Gains Losses
—
—
—
0.61
Gain Loss On Investment Securities
—
—
—
0.61
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
1.52
+56.87%
0.97
-62.70%
2.60
-68.64%
8.29
Change In Prepaid Assets
0.12
+333.05%
-0.05
-125.59%
0.19
-41.37%
0.33
Change In Payables And Accrued Expense
1.41
+36.81%
1.03
-59.00%
2.51
-68.85%
8.05
Change In Accrued Expense
0.72
+414.13%
0.14
+37.40%
0.10
-92.91%
1.43
Change In Payable
0.69
-22.43%
0.89
-63.07%
2.41
-63.64%
6.62
Change In Account Payable
0.69
-22.43%
0.89
-63.07%
2.41
-63.64%
6.62
Change In Other Working Capital
—
0.10
—
—
Change In Other Current Liabilities
0.00
+100.00%
-0.01
+91.35%
-0.10
-16.26%
-0.09
Financing Cash Flow
3.69
-37.67%
5.91
-0.73%
5.96
+219.31%
1.87
Cash Flow From Continuing Financing Activities
3.69
-37.67%
5.91
-0.73%
5.96
+219.31%
1.87
Net Issuance Payments Of Debt
—
—
—
0.00
Issuance Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
0.00
-100.00%
1.35
-92.52%
18.11
0.00
Common Stock Payments
—
0.00
+100.00%
-0.01
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-10.70
0.00
Proceeds From Stock Option Exercised
4.05
-21.88%
5.19
+436.10%
0.97
0.00
Net Other Financing Charges
-0.37
+41.64%
-0.63
+74.07%
-2.42
-2343.61%
-0.10
Changes In Cash
-1.43
+11.05%
-1.61
+41.88%
-2.76
-845.67%
0.37
Beginning Cash Position
1.53
-51.21%
3.14
-46.84%
5.90
+1696.27%
0.33
End Cash Position
0.10
-93.35%
1.53
-51.21%
3.14
+348.67%
0.70
Free Cash Flow
-5.11
+31.99%
-7.52
+13.77%
-8.72
-483.47%
-1.49
Interest Paid Supplemental Data
0.00
0.00
—
—
Income Tax Paid Supplemental Data
0.00
0.00
—
—
Common Stock Issuance
0.00
-100.00%
1.35
-92.52%
18.11
0.00
Issuance Of Capital Stock
0.00
-100.00%
1.35
-92.52%
18.11
+822.07%
1.96
Net Preferred Stock Issuance
—
0.00
+100.00%
-10.70
-644.44%
1.96
Preferred Stock Issuance
—
—
0.00
-100.00%
1.96
Preferred Stock Payments
—
0.00
+100.00%
-10.70
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category